Position in STE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$296,061
-$78,641 QoQ
Shares Held
1,406
-4.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#552
of 822 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $6,739,451 across 9 Medical Devices names. STE ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
25,532 | $1,997,368 | |
| 2 | NVCR |
NovoCure Ltd
|
117,221 | $1,775,898 | |
| 3 | SYK |
Stryker Corp
|
2,985 | $939,797 | |
| 4 | ABT |
Abbott Laboratories
|
5,910 | $536,273 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
1,519 | $445,993 | |
| 6 | STE |
STERIS plc
This page
|
1,406 | $296,061 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
4,478 | $286,636 | |
| 8 | BSX |
Boston Scientific Corp
|
5,476 | $233,715 |
All Filings in STE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $296,061 | 1,406 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $374,702 | 1,478 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||